To protect and expand nationwide access to assisted reproductive technology, including in vitro fertilization.

HR9941 was introduced in the House on July 23, 2026, and referred to the Committees on Energy and Commerce, Veterans' Affairs, Armed Services, Education and Workforce, Ways and Means, and Oversight and Government Reform. The bill is at an early stage with no committee hearings or markup scheduled. It has 121 cosponsors, all Democrats, indicating strong party support but limited bipartisan momentum. The bill does not authorize or appropriate any specific funding amount, so its direct economic impact is zero at this stage. The legislative path requires passage through multiple committees and both chambers, which is uncertain given the current partisan divide. No presidential actions directly relate to this bill. The bill's focus on assisted reproductive technology could affect healthcare providers and insurers, but without specific funding or regulatory mechanisms, no public companies have a clear causal chain to this legislation.